Report #2871128

Received Nov 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 73 yrs
State: MD
Recovered: Unknown
Vaccinated: Oct 28, 2025
Onset: Oct 28, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	HM9N5	—

Symptoms (1)

Product preparation issue

Symptom narrative

Inappropriate Reconstitution Technique; Maladministration of two diluents of the SHINGRIX vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number HM9N5, expiry date 25-MAR-2027) for prophylaxis. On 28-OCT-2025, the patient received Shingrix. On 28-OCT-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Inappropriate Reconstitution Technique) and inappropriate dose of vaccine administered (Verbatim: Maladministration of two diluents of the SHINGRIX vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 28-OCT-2025 The registered pharmacist called to ask about advice on a situation where two diluents of the Shingrix vaccine were administered the same day to a patient.